Publications in collaboration with researchers from Hospital Vall d'Hebron (2)

2022

  1. Determinants of long-term survival in late HIV presenters: The prospective PISCIS cohort study

    eClinicalMedicine, Vol. 52

2008

  1. Didanosine, lamivudine, and efavirenz versus zidovudine, lamivudine, and efavirenz for the initial treatment of hiv type 1 infection: Final analysis (48 weeks) of a prospective, randomized, noninferiority clinical trial, GESIDA 3903

    Clinical Infectious Diseases, Vol. 47, Núm. 8, pp. 1083-1092